Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

被引：431
|
作者：
Kuo, Phillip H.
Kanal, Emanuel
Abu-Alfa, Ali K.
Cowper, Shawn E.
机构：
[1] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Dermatol & Pathol, New Haven, CT 06520 USA
[4] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA USA
来源：
RADIOLOGY | 2007年 / 242卷 / 03期
关键词：
D O I：
10.1148/radiol.2423061640
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease. © RSNA, 2007.
引用
收藏
页码：647 / 649
页数：3
相关论文
共 50 条
  • [31] Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis: Why Did It Happen and What Have We Learned?
    Weinreb, Jeffrey C.
    Abu-Alfa, Ali K.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (06) : 1236 - 1239
  • [32] Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?
    Saab, Georges
    Abu-Alfa, Ali
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 189 (03) : W169 - W169
  • [33] Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency
    Chewning, Rush H.
    Murphy, Kieran J.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2007, 18 (03) : 331 - 333
  • [34] Nephrogenic systemic fibrosis: Recommendations for gadolinium-based contrast use in patients with kidney disease
    Perazella, Mark A.
    Reilly, Robert F.
    SEMINARS IN DIALYSIS, 2008, 21 (02) : 171 - 173
  • [35] Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents
    Hanno Hoppe
    Sara Spagnuolo
    Johannes M. Froehlich
    Helga Nievergelt
    Hans-Peter Dinkel
    Silvia Gretener
    Harriet C. Thoeny
    European Radiology, 2010, 20 : 595 - 603
  • [36] Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation
    Edward, M.
    Quinn, J. A.
    Burden, A. D.
    Newton, B. B.
    Jardine, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (04) : 930 - 930
  • [37] Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis
    Yantasee, Wassana
    Fryxell, Glen E.
    Porter, George A.
    Pattamakomsan, Kanda
    Sukwarotwat, Vichaya
    Chouyyok, Wilaiwan
    Koonsiripaiboon, View
    Xu, Jide
    Raymond, Kenneth N.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2010, 6 (01) : 1 - 8
  • [38] Effect of Different Classes of Gadolinium-based Contrast Agents on Control and Nephrogenic Systemic Fibrosis-derived Fibroblast Proliferation
    Edward, Michael
    Quinn, Jean A.
    Burden, A. David
    Newton, Ben B.
    Jardine, Alan G.
    RADIOLOGY, 2010, 256 (03) : 735 - 743
  • [39] NEPHROGENIC SYSTEMIC FIBROSIS AFTER GADOLINIUM-BASED CONTRAST AGENTS IS NOT ASSOCITATED TO HLA-A,B OR DR TYPES.
    Koefoed-Nielsen, Pernille
    Erikstrup, Christian
    Elmholdt, Tina R.
    Moller, Bjarne K.
    HUMAN IMMUNOLOGY, 2010, 71 : S111 - S111
  • [40] Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents
    Hoppe, Hanno
    Spagnuolo, Sara
    Froehlich, Johannes M.
    Nievergelt, Helga
    Dinkel, Hans-Peter
    Gretener, Silvia
    Thoeny, Harriet C.
    EUROPEAN RADIOLOGY, 2010, 20 (03) : 595 - 603
12345